The thymidine analogue, bromodeoxyuridine, is substituted into DNA dur
ing DNA synthesis and can be used to identify those cells which have p
assed through the S-phase of the cell cycle. Incorporated bromodeoxyur
idine can be detected using anti-bromodeoxyuridine monoclonal antibodi
es which bind to the exposed bromodeoxyuridine in single-stranded DNA
after a suitable denaturation step. Hydrochloric acid is the most comm
only employed denaturation agent in bromodeoxyuridine monoclonal antib
ody methodologies. This preliminary study was to validate the hydrochl
oric acid denaturation step for colorectal tumour tissue infiltrated i
n vivo with bromodeoxyuridine. Standard immunohistochemistry and flow
cytometric techniques using Bu20a were employed across a range of hydr
ochloric acid concentrations. Although high labelling indices were ach
ieved using acid concentrations of 0.10 M HCl, the optimal hydrochlori
c acid concentration was not the same in all tumours. Sensitivity of D
NA to hydrochloric acid denaturation should be carefully considered in
bromodeoxyuridine methodologies using the monoclonal antibody Bu20a.
(C) 1994 Wiley-Liss, Inc.